Aquestive Therapeutics Cash from Operations (TTM) Insights

Aquestive Therapeutics Inc (AQST)

3.52 +0.24 (+7.32%) USD | NASDAQ | May 03, 16:00

3.51 -0.01 (-0.28%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-6.38M
September 30, 2023	6.978M
June 30, 2023	12.13M
March 31, 2023	13.48M
December 31, 2022	-9.819M
September 30, 2022	-26.30M
June 30, 2022	-38.17M
March 31, 2022	-33.36M
December 31, 2021	-32.98M
September 30, 2021	-38.43M
June 30, 2021	-37.68M
March 31, 2021	-45.92M
December 31, 2020	-45.46M

Date	Value
September 30, 2020	-42.52M
June 30, 2020	-49.00M
March 31, 2020	-56.17M
December 31, 2019	-60.21M
September 30, 2019	-52.45M
June 30, 2019	-49.13M
March 31, 2019	-31.46M
December 31, 2018	-12.99M
September 30, 2018	-17.59M
June 30, 2018	9.514M
March 31, 2018	2.701M
December 31, 2017	5.824M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-60.21M

Minimum

Dec 2019

13.48M

Maximum

Mar 2023

-31.13M

Average

-38.17M

Median

Jun 2022

Cash from Operations (TTM) Benchmarks